[go: up one dir, main page]

ES8405380A1 - Un procedimiento para preparar pirimidinas sustituidas. - Google Patents

Un procedimiento para preparar pirimidinas sustituidas.

Info

Publication number
ES8405380A1
ES8405380A1 ES521204A ES521204A ES8405380A1 ES 8405380 A1 ES8405380 A1 ES 8405380A1 ES 521204 A ES521204 A ES 521204A ES 521204 A ES521204 A ES 521204A ES 8405380 A1 ES8405380 A1 ES 8405380A1
Authority
ES
Spain
Prior art keywords
intermediates
medicine
synthesis
making
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES521204A
Other languages
English (en)
Other versions
ES521204A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES521204A0 publication Critical patent/ES521204A0/es
Publication of ES8405380A1 publication Critical patent/ES8405380A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR PIRIMIDINAS SUSTITUIDAS.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON HIDROXIDO DE SODIO O DE POTASIO EN UN ALCANOL DE C 1 A 4; SEGUIDO POR ADICION DE GUANIDINA, PARA OBTENER COMPUESTOS DE FORMULA (I), DONDE X ES UN ANILLO DE SEIS MIEMBROS; QUE CONTIENE TRES DOBLES ENLACES X ES NF O CHF, DOS DOBLES ENLACES X ES -O- ADYACENTE A LA POSICION 5 DEL ANILLO DE FENILO, -NF, -CHF Y OTROS, O UN DOBLE ENLACE X ES -O- ADYACENTE A LA POSICION 5 DEL ANILLO DE FENILO Y -CH2; R Y R SON IGUALES O DIFERENTES Y CADA UNO ESHIDROGENO, HALOGENO, ALCOHILO CON C 1 A 4; R Y R SON IGUALES O DIFERENTES Y CADA UNO ES HIDROGENO, HALOGENO, ALQUENILO DE C 2 A 4, ALQUENILOXI DE C 2 A 4; R ES UN GRUPO ALCOXICARBONILO O ALDEHIDO; Y R ES UN GRUPO ALCOHILO CON C 1 A 4.TIENE APLICACIONES EN EL TRATAMIENTO DE INFECCIONES MICROBIANAS.
ES521204A 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas. Expired ES8405380A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036135 1980-11-11

Publications (2)

Publication Number Publication Date
ES521204A0 ES521204A0 (es) 1984-06-01
ES8405380A1 true ES8405380A1 (es) 1984-06-01

Family

ID=10517217

Family Applications (5)

Application Number Title Priority Date Filing Date
ES506969A Granted ES506969A0 (es) 1980-11-11 1981-11-10 Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES521202A Granted ES521202A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521201A Granted ES521201A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521203A Granted ES521203A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521204A Expired ES8405380A1 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES506969A Granted ES506969A0 (es) 1980-11-11 1981-11-10 Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES521202A Granted ES521202A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521201A Granted ES521201A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.
ES521203A Granted ES521203A0 (es) 1980-11-11 1983-04-02 Un procedimiento para preparar pirimidinas sustituidas.

Country Status (35)

Country Link
US (4) US4438267A (es)
EP (1) EP0051879B1 (es)
JP (1) JPS57114581A (es)
KR (1) KR880001736B1 (es)
AR (1) AR245447A1 (es)
AU (1) AU549449B2 (es)
CA (1) CA1186310A (es)
CS (1) CS273153B2 (es)
CY (1) CY1419A (es)
DD (1) DD201896A5 (es)
DE (1) DE3173752D1 (es)
DK (1) DK172884B1 (es)
EG (1) EG16107A (es)
ES (5) ES506969A0 (es)
FI (1) FI76333C (es)
GB (1) GB2087881B (es)
GR (1) GR81317B (es)
HK (1) HK23388A (es)
HU (1) HU188762B (es)
IE (1) IE52128B1 (es)
IL (1) IL64256A (es)
IT (1) IT1210589B (es)
MC (1) MC1418A1 (es)
MY (1) MY8600678A (es)
NO (2) NO160137C (es)
NZ (1) NZ198932A (es)
PH (2) PH22654A (es)
PL (4) PL139523B1 (es)
PT (1) PT73960B (es)
RU (1) RU1819264C (es)
SG (1) SG62686G (es)
SU (4) SU1424732A3 (es)
YU (5) YU42444B (es)
ZA (1) ZA817780B (es)
ZM (1) ZM9481A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
DK190983A (da) * 1982-05-01 1983-11-02 Wellcome Found 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
ZA833067B (en) * 1982-05-01 1984-12-24 Wellcome Found Antibacterial compounds
US4590271A (en) * 1982-05-01 1986-05-20 Burroughs Wellcome Co. 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
US4587341A (en) * 1982-05-07 1986-05-06 Burroughs Wellcome Co. 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
GB8603962D0 (en) * 1986-02-18 1986-03-26 Wellcome Found Chemical compositions
LU86703A1 (fr) * 1986-12-08 1988-07-14 Oreal Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
GB8903978D0 (en) * 1989-02-22 1989-04-05 Coopers Animal Health Chemical compositions
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
JP3309340B2 (ja) * 1995-12-04 2002-07-29 アルピダ・アーゲー ジアミノピリミジン、それらを含む医薬組成物及びそれらの抗菌剤としての用途
RU2141322C1 (ru) * 1997-08-12 1999-11-20 Голощапов Николай Михайлович Иммуномодулятор с антимикобактериальной активностью "изофон", способ его получения и применения
GB0016877D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Chemical compounds
WO2002010156A1 (en) * 2000-07-29 2002-02-07 Arpida Ag Benzofuran derivatives and their use as antibacterial agents
US7678805B2 (en) 2001-06-29 2010-03-16 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)
EP1401415B1 (en) * 2001-06-29 2006-06-21 AB Science Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases
US7727731B2 (en) * 2001-06-29 2010-06-01 Ab Science Potent, selective and non toxic c-kit inhibitors
CA2452371A1 (en) * 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating allergic diseases
ATE401078T1 (de) * 2001-09-20 2008-08-15 Ab Science Die verwendung von c-kithemmern zur förderung des haarwuchses
US20040242601A1 (en) * 2001-09-20 2004-12-02 Alain Moussy Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
DE60225590T2 (de) * 2001-09-20 2008-09-25 Ab Science C-kithemmer zur behandlung von bakteriellen infektionen
EP1651639B1 (en) * 2003-07-11 2010-05-26 Arpida AG, Benzofuran derivatives and their use in the treatment of microbial infections
HUP0700605A3 (en) * 2005-02-18 2008-02-28 Arpida Ag Novel processes for the preparation of a benzofuran
EP1924565B1 (en) * 2005-09-01 2016-09-14 F.Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p3x2/3 modulators
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
US20120122819A1 (en) * 2009-06-12 2012-05-17 Socpra - Sciences Et Genie S.E.C. Guanine riboswitch binding compounds and their use as antibiotics
CN102649786B (zh) * 2011-02-28 2014-08-27 郑州福源动物药业有限公司 一种2，4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2，4-(1h，3h)嘧啶的制备方法
CN103755684B (zh) * 2014-02-10 2015-09-09 青岛蔚蓝生物股份有限公司 一种巴喹普林的制备方法
JP7538153B2 (ja) * 2019-06-06 2024-08-21 ベイジン タイド ファーマシューティカル カンパニー リミテッド Ｐ２ｘ３及び／又はｐ２ｘ２／３受容体アンタゴニスト、それを含む医薬組成物及びその使用
CN110818694B (zh) * 2019-11-18 2023-04-21 上海医药工业研究院有限公司 艾拉普林中间体及其应用
US20240226100A1 (en) * 2021-04-09 2024-07-11 The Trustees Of The University Of Pennsylvania Control of protein expression with tmp-protac compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3956327A (en) * 1969-03-06 1976-05-11 Burroughs Wellcome Co. Method of preparing 2,4-diamino-5-benzyl pyrimidines
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
GB1468374A (en) 1974-03-06 1977-03-23 Wellcome Found Process for preparing a pyrimidine derivative
US4039543A (en) 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2730467A1 (de) * 1977-07-06 1979-01-18 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use

Also Published As

Publication number Publication date
GB2087881B (en) 1985-05-15
IL64256A (en) 1988-01-31
IL64256A0 (en) 1982-02-28
AU7733481A (en) 1982-05-20
CA1186310A (en) 1985-04-30
YU198383A (en) 1984-04-30
PL233754A1 (en) 1983-08-01
GR81317B (es) 1984-12-11
ZA817780B (en) 1983-06-29
PT73960A (en) 1981-12-01
PL139827B1 (en) 1987-02-28
PH25053A (en) 1991-01-28
PL239280A1 (en) 1983-08-01
IT8149676A0 (it) 1981-11-10
YU266381A (en) 1984-04-30
NO160137B (no) 1988-12-05
CS273153B2 (en) 1991-03-12
SU1535379A3 (ru) 1990-01-07
AR245447A1 (es) 1994-01-31
US4587342A (en) 1986-05-06
KR830007628A (ko) 1983-11-04
YU43551B (en) 1989-08-31
YU42444B (en) 1988-08-31
DE3173752D1 (en) 1986-03-20
DK496681A (da) 1982-05-12
US4603136A (en) 1986-07-29
DD201896A5 (de) 1983-08-17
PL239279A1 (en) 1983-08-01
EG16107A (en) 1987-10-30
DK172884B1 (da) 1999-09-06
AU549449B2 (en) 1986-01-30
NO160137C (no) 1989-03-15
FI76333C (fi) 1988-10-10
ES8307759A1 (es) 1983-07-01
PL139523B1 (en) 1987-01-31
YU198283A (en) 1984-04-30
SU1318148A3 (ru) 1987-06-15
IE52128B1 (en) 1987-06-24
MY8600678A (en) 1986-12-31
YU46697B (sh) 1994-04-05
GB2087881A (en) 1982-06-03
ES8405377A1 (es) 1984-06-01
FI76333B (fi) 1988-06-30
FI813546L (fi) 1982-05-12
IT1210589B (it) 1989-09-14
SU1306473A3 (ru) 1987-04-23
PL139427B1 (en) 1987-01-31
CS825781A2 (en) 1990-07-12
ES521201A0 (es) 1984-06-01
ES8405379A1 (es) 1984-06-01
SU1424732A3 (ru) 1988-09-15
ES521204A0 (es) 1984-06-01
ES8405378A1 (es) 1984-06-01
CY1419A (en) 1988-04-22
PT73960B (en) 1983-11-23
ES521202A0 (es) 1984-06-01
SG62686G (en) 1987-03-27
NO1994029I1 (no) 1994-12-29
JPH0474351B2 (es) 1992-11-26
ES521203A0 (es) 1984-06-01
IE812631L (en) 1982-05-11
EP0051879A3 (en) 1982-08-04
EP0051879B1 (en) 1986-02-05
PL139828B1 (en) 1987-02-28
KR880001736B1 (ko) 1988-09-10
MC1418A1 (fr) 1982-10-18
PL239278A1 (en) 1983-08-01
YU144288A (en) 1990-04-30
US4438267A (en) 1984-03-20
YU198183A (en) 1984-04-30
ES506969A0 (es) 1983-07-01
JPS57114581A (en) 1982-07-16
NZ198932A (en) 1985-05-31
HK23388A (en) 1988-04-08
PH22654A (en) 1988-10-28
NO813804L (no) 1982-05-12
HU188762B (en) 1986-05-28
US4761475A (en) 1988-08-02
RU1819264C (ru) 1993-05-30
ZM9481A1 (en) 1983-11-21
EP0051879A2 (en) 1982-05-19

Similar Documents

Publication Publication Date Title
ES8307759A1 (es) Un procedimiento para la preparacion de pirimidinas sustitu-idas.
NZ208529A (en) 2-pyrimidinyl-1-piperazine derivatives and pharmaceutical compositions
ES472661A1 (es) Procedimiento para la preparacion de nuevos nitroimidazoles
GR3007385T3 (es)
IL81002A0 (en) Pyrazoline derivatives,processes for their preparation and pesticidal compositions containing the same
IL64504A (en) Aminoalkoxyphenyl substituted quinazolinones and pyridopyrimidinones,their preparation and pharmaceutical compositions containing them
IL60086A0 (en) Pyrimidine compounds,their preparation and pharmaceutical compositions containing them
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
PH17390A (en) Imidazolylphenyl amidines,pharmaceutical compositions containing same and use thereof
JPS5592383A (en) Novel substituted 55*22imidazolinee22yl** aminopyrimidine*its manufacture and its use as drug
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
ES472284A1 (es) Procedimiento para la preparacion de 6-deoxineamina
JPS57123164A (en) Hydroxyphenyltetrahydropyridine novel derivatives and their salts, manufacture and intermediates, use as drug and composition containing same
IL62276A0 (en) 3,3-dimethyl-1-phenoxy-butan-2-ols,their preparation and their use as intermediates for the synthesis of fungicides
DE3165337D1 (en) Bicyclooctane compounds, their production, compositions containing them and their pharmaceutical use
ES483165A1 (es) Un procedimiento para preparar ureas substituidas.
ES424274A1 (es) Procedimiento para la preparacion de 2,4-diamino-5-(3',5'- dimetoxi-4'-metoxialcoxibencil)-pirimidinas.
ES475960A1 (es) Procedimiento para la preparacion de 3-di-n-propil-acetoxi- venzodiazepin-2-onas.
KE3650A (en) Substituted pyrimidines,their synthesis and compositions containing them,their use in medicine and intermediates for making them
DE2960389D1 (en) 4-alkyl- and 4-allyl-thio-, sulfinyl- and sulfonyl-methyl-2-amino-6-n,n'-dimethylcarbamoyloxy pyrimidines, process for their preparation, compositions containing them and their use as insecticides
IL60169A0 (en) Guanidines,their production and pharmaceutical compositions containing them
ES483277A1 (es) Procedimiento para la obtencion de n-amino-3,4,5-tihidroxi- piperidinas
JO1183B1 (en) Benzodine isoxazolyl compounds
IL46008A (en) 2,4-diamino-5-(4-halo-3,5-dialkoxybenzyl)-pyrimidines, their manufacture and antibacterial compositions containing them
JPS5788167A (en) 5-substituted uracil derivative, manufacture and medicinal composition containing same